Molecular Partners AG
MOLN
$3.88
-$0.07-1.77%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -16.45M | -15.83M | -14.79M | -24.73M | -18.66M |
| Total Depreciation and Amortization | 627.00K | 583.30K | 658.80K | 670.40K | 614.00K |
| Total Amortization of Deferred Charges | -- | 57.60K | -- | -- | -- |
| Total Other Non-Cash Items | 1.13M | 1.51M | 1.22M | 3.56M | 2.13M |
| Change in Net Operating Assets | -3.13M | -280.40K | 510.00K | 4.61M | -3.09M |
| Cash from Operations | -17.83M | -13.96M | -12.41M | -15.88M | -19.00M |
| Capital Expenditure | -- | -174.00K | -38.80K | -116.40K | -498.30K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -4.92M | 15.13M | 13.37M | 18.26M | 39.39M |
| Cash from Investing | -4.92M | 14.96M | 13.33M | 18.15M | 38.89M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -300.00K | -300.00K | -305.00K | -304.00K | -303.00K |
| Issuance of Common Stock | 8.00K | 0.00 | 1.00K | 61.00K | 1.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -365.50K | -375.50K | -380.00K | -294.60K | -335.90K |
| Foreign Exchange rate Adjustments | 76.30K | -256.60K | -65.00K | -1.24M | -93.40K |
| Miscellaneous Cash Flow Adjustments | -- | -2.50K | 2.50K | -1.20K | -- |
| Net Change in Cash | -23.03M | 368.00K | 480.00K | 731.00K | 19.46M |